IBDEI2KD ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43502,1,4,0)
 ;;=4^I83.222
 ;;^UTILITY(U,$J,358.3,43502,2)
 ;;=^5008005
 ;;^UTILITY(U,$J,358.3,43503,0)
 ;;=I83.223^^167^2078^149
 ;;^UTILITY(U,$J,358.3,43503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43503,1,3,0)
 ;;=3^Varic Veins Lt LE w/ Ulc of Ankle & Inflam
 ;;^UTILITY(U,$J,358.3,43503,1,4,0)
 ;;=4^I83.223
 ;;^UTILITY(U,$J,358.3,43503,2)
 ;;=^5008006
 ;;^UTILITY(U,$J,358.3,43504,0)
 ;;=I83.224^^167^2078^153
 ;;^UTILITY(U,$J,358.3,43504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43504,1,3,0)
 ;;=3^Varic Veins Lt LE w/ Ulc of Heel/Midfoot & Inflam
 ;;^UTILITY(U,$J,358.3,43504,1,4,0)
 ;;=4^I83.224
 ;;^UTILITY(U,$J,358.3,43504,2)
 ;;=^5008007
 ;;^UTILITY(U,$J,358.3,43505,0)
 ;;=I83.225^^167^2078^157
 ;;^UTILITY(U,$J,358.3,43505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43505,1,3,0)
 ;;=3^Varic Veins Lt LE w/ Ulc of Oth Part of Ft & Inflam
 ;;^UTILITY(U,$J,358.3,43505,1,4,0)
 ;;=4^I83.225
 ;;^UTILITY(U,$J,358.3,43505,2)
 ;;=^5008008
 ;;^UTILITY(U,$J,358.3,43506,0)
 ;;=I83.228^^167^2078^154
 ;;^UTILITY(U,$J,358.3,43506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43506,1,3,0)
 ;;=3^Varic Veins Lt LE w/ Ulc of Oth Part LE & Inflam
 ;;^UTILITY(U,$J,358.3,43506,1,4,0)
 ;;=4^I83.228
 ;;^UTILITY(U,$J,358.3,43506,2)
 ;;=^5008009
 ;;^UTILITY(U,$J,358.3,43507,0)
 ;;=I83.91^^167^2078^46
 ;;^UTILITY(U,$J,358.3,43507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43507,1,3,0)
 ;;=3^Asymptomatic Varicose Veins Rt LE
 ;;^UTILITY(U,$J,358.3,43507,1,4,0)
 ;;=4^I83.91
 ;;^UTILITY(U,$J,358.3,43507,2)
 ;;=^5008020
 ;;^UTILITY(U,$J,358.3,43508,0)
 ;;=I83.92^^167^2078^45
 ;;^UTILITY(U,$J,358.3,43508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43508,1,3,0)
 ;;=3^Asymptomatic Varicose Veins Lt LE
 ;;^UTILITY(U,$J,358.3,43508,1,4,0)
 ;;=4^I83.92
 ;;^UTILITY(U,$J,358.3,43508,2)
 ;;=^5008021
 ;;^UTILITY(U,$J,358.3,43509,0)
 ;;=I83.93^^167^2078^44
 ;;^UTILITY(U,$J,358.3,43509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43509,1,3,0)
 ;;=3^Asymptomatic Varicose Veins Bil LE
 ;;^UTILITY(U,$J,358.3,43509,1,4,0)
 ;;=4^I83.93
 ;;^UTILITY(U,$J,358.3,43509,2)
 ;;=^5008022
 ;;^UTILITY(U,$J,358.3,43510,0)
 ;;=I89.0^^167^2078^117
 ;;^UTILITY(U,$J,358.3,43510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43510,1,3,0)
 ;;=3^Lymphedema NEC
 ;;^UTILITY(U,$J,358.3,43510,1,4,0)
 ;;=4^I89.0
 ;;^UTILITY(U,$J,358.3,43510,2)
 ;;=^5008073
 ;;^UTILITY(U,$J,358.3,43511,0)
 ;;=I87.2^^167^2078^170
 ;;^UTILITY(U,$J,358.3,43511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43511,1,3,0)
 ;;=3^Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,43511,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,43511,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,43512,0)
 ;;=K55.0^^167^2078^32
 ;;^UTILITY(U,$J,358.3,43512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43512,1,3,0)
 ;;=3^AC Intestine Vascular Disorders
 ;;^UTILITY(U,$J,358.3,43512,1,4,0)
 ;;=4^K55.0
 ;;^UTILITY(U,$J,358.3,43512,2)
 ;;=^5008705
 ;;^UTILITY(U,$J,358.3,43513,0)
 ;;=K55.1^^167^2078^74
 ;;^UTILITY(U,$J,358.3,43513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43513,1,3,0)
 ;;=3^Chr Intestine Vascular Disorders
 ;;^UTILITY(U,$J,358.3,43513,1,4,0)
 ;;=4^K55.1
 ;;^UTILITY(U,$J,358.3,43513,2)
 ;;=^5008706
 ;;^UTILITY(U,$J,358.3,43514,0)
 ;;=N18.9^^167^2078^75
 ;;^UTILITY(U,$J,358.3,43514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43514,1,3,0)
 ;;=3^Chr Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,43514,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,43514,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,43515,0)
 ;;=N28.0^^167^2078^108
 ;;^UTILITY(U,$J,358.3,43515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43515,1,3,0)
 ;;=3^Kidney Ischemia & Infarction
